{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:21:27Z","timestamp":1781634087680,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.leukres.2021.106725","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T20:01:25Z","timestamp":1633377685000},"page":"106725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Overview of clinical and genetic features of CML patients with variant Philadelphia translocations involving chromosome 7: A case series"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2228-0632","authenticated-orcid":false,"given":"Ayse Gul","family":"Bayrak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8072-0646","authenticated-orcid":false,"given":"Aynur","family":"Daglar Aday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9049-4654","authenticated-orcid":false,"given":"Akif Selim","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2555-5024","authenticated-orcid":false,"given":"Meliha","family":"Nalcaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3040-4052","authenticated-orcid":false,"given":"Mustafa Murat","family":"Ozbalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9420-4543","authenticated-orcid":false,"given":"Kivanc","family":"Cefle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8809-7462","authenticated-orcid":false,"given":"Sukru","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9435-009X","authenticated-orcid":false,"given":"Sukru","family":"Palanduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.leukres.2021.106725_bib0005","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2021.106725_bib0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clml.2016.09.007","article-title":"Predictive and prognostic implications of variant philadelphia translocations in CML: experience from a tertiary oncology center in Southern India","volume":"17","author":"Kanakasetty","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"2","key":"10.1016\/j.leukres.2021.106725_bib0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5045\/br.2018.53.2.152","article-title":"The incidence of atypical patterns of BCR-ABL1 rearrangement and molecular-cytogenetic response to tyrosine kinase inhibitor therapy in newly diagnosed cases with chronic myeloid leukemia (CML)","volume":"53","author":"\u0160vabek","year":"2018","journal-title":"Blood Res."},{"issue":"1","key":"10.1016\/j.leukres.2021.106725_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cancergencyto.2009.05.010","article-title":"Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9","volume":"194","author":"Bennour","year":"2009","journal-title":"Cancer Genet. Cytogenet."},{"issue":"4","key":"10.1016\/j.leukres.2021.106725_bib0025","first-page":"17","article-title":"A rare t (9; 12; 22) (q34; q23; q11) translocation in a patient with typical chronic myeloid leukemia: a case report","volume":"2","author":"Azma","year":"2012","journal-title":"J. Hematol. Malig."},{"key":"10.1016\/j.leukres.2021.106725_bib0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.critrevonc.2015.08.020","article-title":"Chronic myeloid leukemia: relevance of cytogenetic and molecular assays","volume":"97","author":"Bennour","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"25","key":"10.1016\/j.leukres.2021.106725_bib0035","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1182\/blood-2011-01-328294","volume":"117","author":"Marzocchi","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2021.106725_bib0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cancergencyto.2008.01.005","article-title":"Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy","volume":"182","author":"Richebourg","year":"2008","journal-title":"Cancer Genet. Cytogenet."},{"issue":"2","key":"10.1016\/j.leukres.2021.106725_bib0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-4608(91)90145-K","article-title":"Complex chromosomal translocations in the Philadelphia chromosome leukemias. Serial translocations or a concerted genomic rearrangement?","volume":"57","author":"Fitzgerald","year":"1991","journal-title":"Cancer Genet. Cytogenet."},{"issue":"2","key":"10.1016\/j.leukres.2021.106725_bib0050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046636","article-title":"Cytogenetic and molecular genetic evolution of chronic myeloid leukemia","volume":"107","author":"Johansson","year":"2002","journal-title":"Acta Haematol."},{"issue":"2","key":"10.1016\/j.leukres.2021.106725_bib0055","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5530\/ami.2015.5.4","article-title":"A 3-way rare variant ph translocation t(7;9;22) in a patient with chronic myeloid leukemia","volume":"2","author":"Shan","year":"2015","journal-title":"Acta Med. Int."},{"issue":"4","key":"10.1016\/j.leukres.2021.106725_bib0060","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cyto.b.21775","article-title":"Immunophenotypic features of myeloid neoplasms associated with chromosome 7 abnormalities","volume":"96","author":"Chen","year":"2019","journal-title":"Cytometry B Clin. Cytom."},{"issue":"2","key":"10.1016\/j.leukres.2021.106725_bib0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cancergencyto.2006.10.006","article-title":"On the genesis and prognosis of variant translocations in chronic myeloid leukemia","volume":"173","author":"Gorusu","year":"2007","journal-title":"Cancer Genet. Cytogenet."},{"issue":"4","key":"10.1016\/j.leukres.2021.106725_bib0070","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.leukres.2021.106725_bib0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2141.2001.02778.x","article-title":"Variant Philadelphia translocations in chronic myeloid leukaemia can mimic typical blast crisis chromosome abnormalities or classic t(9;22): a report of two cases","volume":"113","author":"Reid","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.leukres.2021.106725_bib0080","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12288-018-0941-1","article-title":"Prevalence of chromosome 7 abnormalities in myelodysplastic syndrome and acute myeloid leukemia: a single center study and brief literature review","volume":"34","author":"Gupta","year":"2018","journal-title":"Indian J. Hematol. Blood Transfus."},{"issue":"1","key":"10.1016\/j.leukres.2021.106725_bib0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-4608(02)00606-4","article-title":"Constitutional rearrangements of 7q22 in hematologic malignancies. A new case report","volume":"139","author":"Forrest","year":"2002","journal-title":"Cancer Genet. Cytogenet."},{"issue":"2","key":"10.1016\/j.leukres.2021.106725_bib0090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/0973-1482.34695","article-title":"Conventional and fluorescence in situ hybridization analysis of three-way complex BCR-ABL rearrangement in a chronic myeloid leukemia patient","volume":"3","author":"Ganguly","year":"2007","journal-title":"J. Cancer Res. Ther."},{"issue":"1","key":"10.1016\/j.leukres.2021.106725_bib0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cancergencyto.2003.08.018","article-title":"A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome","volume":"150","author":"Zagaria","year":"2004","journal-title":"Cancer Genet. Cytogenet."},{"issue":"3","key":"10.1016\/j.leukres.2021.106725_bib0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12185-012-1018-9","article-title":"Novel four-way Ph translocation t(9;22;7;1)(q34;q11;q22;p13) in a chronic myeloid leukemia patient receiving tyrosine kinase inhibitor therapy","volume":"95","author":"Adriana","year":"2012","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106725_bib0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1755-8166-5-20","article-title":"A novel five-way translocation t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) involving Ph chromosome in a patient of chronic myeloid leukemia: a case report","volume":"5","author":"Yokota","year":"2012","journal-title":"Mol. Cytogenet."},{"key":"10.1016\/j.leukres.2021.106725_bib0110","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/187125","article-title":"Complex variant t(9;22) chromosome translocations in five cases of chronic myeloid leukemia","volume":"2009","author":"Valencia","year":"2009","journal-title":"Adv. Hematol."},{"issue":"7","key":"10.1016\/j.leukres.2021.106725_bib0115","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.cancergen.2011.06.004","article-title":"Cytogenetic and molecular characteristics of 25 Chilean patients with a variant Ph translocation","volume":"204","author":"Legues","year":"2011","journal-title":"Cancer Genet."},{"issue":"4","key":"10.1016\/j.leukres.2021.106725_bib0120","first-page":"5","article-title":"Chronic myeloid leukemia with variant chromosomal translocations: results of treatment with imatinib mesylate","volume":"11","author":"Bhise","year":"2012","journal-title":"Online J. Health Allied Sci."},{"issue":"2","key":"10.1016\/j.leukres.2021.106725_bib0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2141.2004.04899.x","article-title":"Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome","volume":"125","author":"El-Zimaity","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.leukres.2021.106725_bib0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cancergencyto.2008.02.002","article-title":"A novel five-way chromosomal translocation observed in chronic myelogenous leukemia","volume":"183","author":"Ikuta","year":"2008","journal-title":"Cancer Genet. Cytogenet."},{"issue":"3","key":"10.1016\/j.leukres.2021.106725_bib0135","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2141.2003.04291.x","article-title":"Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia","volume":"121","author":"Reid","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.leukres.2021.106725_bib0140","first-page":"5705","article-title":"Conventional and molecular cytogenetic studies to characterize 32 complex variant Philadelphia translocations in patients with chronic myeloid leukemia","volume":"17","author":"Costa","year":"2019","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.leukres.2021.106725_bib0145","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/sj.leu.2402108","article-title":"Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia","volume":"15","author":"Lezon-Geyda","year":"2001","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.leukres.2021.106725_bib0150","doi-asserted-by":"crossref","first-page":"16059","DOI":"10.1074\/jbc.M212935200","article-title":"The histone deacetylase 9 gene encodes multiple protein isoforms","volume":"278","author":"Petrie","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2021.106725_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113698","article-title":"Epigenetic mechanisms underlying the therapeutic effects of HDAC inhibitors in chronic myeloid leukemia","volume":"173","author":"Lernoux","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.leukres.2021.106725_bib0160","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2010.08301.x","article-title":"Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia","volume":"150","author":"Moreno","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"17","key":"10.1016\/j.leukres.2021.106725_bib0165","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.1158\/0008-5472.CAN-06-1482","article-title":"TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer","volume":"66","author":"Perner","year":"2006","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.leukres.2021.106725_bib0170","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.leu.2403327","article-title":"Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children\u2019s Cancer Group","volume":"18","author":"Heerema","year":"2004","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.leukres.2021.106725_bib0175","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood.V89.6.2036","article-title":"Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias","volume":"89","author":"Fischer","year":"1997","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2021.106725_bib0180","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3324\/haematol.2010.036558","article-title":"The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia\/lymphoma and t(7;8)(q22;p11)","volume":"96","author":"Wasag","year":"2011","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.leukres.2021.106725_bib0185","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1182\/blood-2012-04-426965","article-title":"CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia","volume":"121","author":"McNerney","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2021.106725_bib0190","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0165-4608(91)90148-N","article-title":"Atypical (7;19) translocation in acute myelomonocytic leukemia","volume":"57","author":"Sherer","year":"1991","journal-title":"Cancer Genet. Cytogenet."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621017264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621017264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:02:53Z","timestamp":1758934973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621017264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":38,"alternative-id":["S0145212621017264"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106725","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview of clinical and genetic features of CML patients with variant Philadelphia translocations involving chromosome 7: A case series","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106725"}}